National Health Investors, Inc. (NYSE:NHI – Get Free Report) has been assigned an average rating of “Moderate Buy” from the six research firms that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $75.33.
Several research analysts have weighed in on the company. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price objective for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Bank of America began coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective on the stock. Finally, Truist Financial decreased their target price on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research report on Monday, December 23rd.
View Our Latest Analysis on National Health Investors
Institutional Trading of National Health Investors
National Health Investors Price Performance
NYSE NHI opened at $67.24 on Tuesday. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The firm has a market capitalization of $3.05 billion, a price-to-earnings ratio of 23.11, a price-to-earnings-growth ratio of 4.86 and a beta of 1.06. The company has a 50 day simple moving average of $73.44 and a 200-day simple moving average of $75.87. National Health Investors has a 52-week low of $51.59 and a 52-week high of $86.13.
National Health Investors (NYSE:NHI – Get Free Report) last issued its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The company had revenue of $63.32 million for the quarter, compared to analyst estimates of $67.93 million. During the same period last year, the business earned $1.08 EPS. The company’s quarterly revenue was up 1.7% on a year-over-year basis. Equities research analysts predict that National Health Investors will post 4.42 earnings per share for the current fiscal year.
National Health Investors Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.35%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio is 123.71%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Stories
- Five stocks we like better than National Health Investors
- Election Stocks: How Elections Affect the Stock Market
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- 10 Best Airline Stocks to Buy
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What Are Growth Stocks and Investing in Them
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.